Summary & Overview
HCPCS Level II J1800: Propranolol HCl Injection, Up to 1 mg
HCPCS Level II code J1800 denotes an injectable dose of propranolol hydrochloride billed “up to 1 mg.” This code captures parenteral delivery of a nonselective beta-blocker commonly used for acute cardiovascular and other indications where intravenous or intramuscular administration is required. Nationally, accurate coding for injectable agents like propranolol affects hospital and clinic medication billing, inventory management, and payer adjudication.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find: benchmark context for how J1800 is applied across settings, common clinical contexts for injectable propranolol, and guidance on which payers cover injectable medication services generally. The publication summarizes available policy considerations and payer coverage patterns when data are available and notes where input is not provided.
The report is intended for billing professionals, pharmacy managers, and clinical coders who need a concise reference on J1800 — its clinical meaning, typical sites of service, and the primary payers that process claims for injectable propranolol.
Billing Code Overview
HCPCS Level II code J1800 represents the administration of propranolol hydrochloride by injection, billed per unit defined as up to 1 mg. This code is used when propranolol HCl is provided as an injectable medication.
-
Service type: Injectable medication administration
-
Typical site of service: Hospital inpatient, hospital outpatient, emergency department, or other clinic settings where parenteral medications are administered
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient infusion clinic, emergency department, or perioperative area with symptomatic supraventricular tachycardia, atrial fibrillation with rapid ventricular rate, hypertrophic obstructive cardiomyopathy pre-procedural management, or acute performance of diagnostic autonomic testing requiring short-acting beta blockade. The patient has an order for intravenous propranolol hydrochloride, dosed in milligrams, for acute rate control or diagnostic/therapeutic effect.
Clinical workflow: The physician documents indication, dose (in mg), route (intravenous), and consent as applicable. Nursing verifies allergies and baseline vital signs, prepares the J1800 product per facility protocol, and administers under monitoring. Vital signs and cardiac rhythm are continuously monitored before, during, and after administration. Medication administration is documented in the medical record including lot/expiration when necessary and any immediate adverse reactions. Billing uses HCPCS Level II code J1800 with an applicable modifier to reflect circumstances (for example, provider status, discarded drug amount, or split/shared service).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug discarded/not administered to any patient |